Autoantibodies in hospitalised patients with COVID‐19
Abstract Objectives CD209L and its homologous protein CD209 act as alternative entry receptors for the SARS‐CoV‐2 virus and are highly expressed in the virally targeted tissues. We tested for the presence and clinical features of autoantibodies targeting these receptors and compared these with autoa...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2024-01-01
|
| シリーズ: | Clinical & Translational Immunology |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1002/cti2.70019 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
